Valuation: ConvaTec Group Plc

Market Cap 6.47B 5.81B 5.35B 4.86B 9.2B 607B 9.45B 64.06B 25.52B 325B 24.29B 23.78B 1,028B P/E 2026 *
25.7x
P/E 2027 * 17.4x
Enterprise Value 7.88B 7.07B 6.51B 5.91B 11.19B 739B 11.51B 77.98B 31.07B 396B 29.57B 28.95B 1,251B EV / Sales 2026 *
3.09x
EV / Sales 2027 * 2.82x
Free-Float
95.08%
Yield 2026 *
2.41%
Yield 2027 * 2.76%
1 week+2.05%
Current month+1.72%
1 month+13.00%
3 months+6.42%
6 months+21.15%
Current year+2.22%
1 week 246.2
Extreme 246.2
257.6
1 month 221
Extreme 221
257.6
Current year 193
Extreme 193
259.3
1 year 193
Extreme 193
259.3
3 years 193
Extreme 193
311.2
5 years 165.3
Extreme 165.3
311.2
10 years 113.25
Extreme 113.25
349.1
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Director/Board Member 66 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/10/26 Buy

Director

24,400 0.0013%
26/5/26 Buy

Chief Executive Officer

50,000 0.0026%
26/5/26 Buy

Chief Financial Officer

24,993 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.05%+5.88%+19.40% 6.52B
-0.05%+0.97%-12.26%+17.55% 191B
-1.17%+2.74%+9.64%+43.73% 126B
-0.44%+4.42%-8.66%+18.52% 124B
-1.57%+1.82%-39.83%+7.26% 98.14B
+0.85%+2.41%-4.37%+76.50% 65.98B
-1.23%+7.29%+17.05%-9.39% 58.63B
-1.42%+3.66%-1.82%+62.49% 55.67B
+0.91%-2.83%-4.83%+53.96% 48.78B
+1.08%+3.41%+4.00%-4.71% 36.03B
Average -0.31%+2.24%-3.52%+28.53% 81B
Weighted average by Cap. -0.47%+2.50%-6.86%+27.66%

Financials

2026 *2027 *
Net sales 2.55B 2.29B 2.11B 1.92B 3.63B 239B 3.73B 25.27B 10.07B 128B 9.59B 9.38B 406B 2.73B 2.45B 2.26B 2.05B 3.88B 256B 3.99B 27.04B 10.78B 137B 10.26B 10.04B 434B
Net income 248M 222M 205M 186M 352M 23.24B 362M 2.45B 977M 12.45B 930M 910M 39.36B 367M 329M 303M 275M 521M 34.39B 536M 3.63B 1.45B 18.43B 1.38B 1.35B 58.25B
Net Debt 1.41B 1.26B 1.16B 1.06B 2B 132B 2.05B 13.93B 5.55B 70.69B 5.28B 5.17B 223B 1.23B 1.1B 1.02B 922M 1.75B 115B 1.79B 12.16B 4.84B 61.71B 4.61B 4.51B 195B
Projected Income Statement - Annual - ConvaTec Group Plc
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
10/11/26 GBX 248.60 0.00% 3,115,854
09/11/26 GBX 248.60 -0.72% 3,927,195
06/11/26 GBX 250.40 -1.03% 5,173,119
05/11/26 GBX 253.00 -0.39% 10,384,153
04/11/26 GBX 254.00 +4.27% 9,359,978
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - ConvaTec Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.312USD
Average target price
4.023USD
Spread / Average Target
+21.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ConvaTec Group Plc
  1. Stock Market
  2. Stocks
  3. CTEC Stock